Broadcom named strategic vendor for Walmart virtualization solutions
Jennifer Saenz, Executive Vice President of Pharmacy & eCommerce at Albertsons Companies , Inc. (NYSE:ACI), recently sold 30,813 shares of the company’s Class A common stock. The shares were sold at prices ranging from $21.88 to $21.95, totaling approximately $674,000. Following this transaction, Saenz holds 179,297 shares directly. The sale was disclosed in a filing with the Securities and Exchange Commission dated April 29, 2025. Based on InvestingPro’s Fair Value analysis, the stock appears slightly overvalued at current levels. Subscribers can access 10+ additional ProTips and a comprehensive Pro Research Report for deeper insights into Albertsons’ valuation and growth prospects.
In other recent news, Albertsons Companies Inc. reported its fourth-quarter 2025 earnings, surpassing analyst expectations with an adjusted earnings per share (EPS) of $0.46 and revenue of $18.8 billion, exceeding the forecasted $18.63 billion. Despite these positive results, Albertsons’ stock target was adjusted by several analysts. Evercore ISI reduced their price target to $22 from $23, maintaining an In Line rating, while UBS also cut their target to $22 from $24, holding a Neutral stance. These revisions were influenced by Albertsons’ guidance indicating a need for increased investment in fiscal year 2025, which is expected to result in a 5.5% decline in EBITDA.
Tigress Financial Partners, however, took a more optimistic view, raising Albertsons’ stock target to $28 and maintaining a Buy rating. Tigress highlighted Albertsons’ strategic focus on digital and omnichannel growth, as well as the expansion of its loyalty program, as drivers of potential growth in pharmacy and e-commerce sales. The company has also been recognized for its strength in these areas, with digital sales growing by 24% and pharmacy revenue increasing by 18% in the fourth quarter.
Albertsons’ strategic initiatives include enhancing digital capabilities, expanding its "Customers for Life" strategy, and developing its private label products. These efforts are aimed at differentiating the company in a competitive market and driving long-term growth. As the company navigates through these investments, analysts and investors will closely watch its performance against its long-term growth targets.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.